Germline genetic contributions to risk for esophageal adenocarcinoma, barrett's esophagus, and gastroesophageal reflux

Journal of the National Cancer Institute

Volumn 105, Issue 22, 2013, Pages 1711-1718

  Ek, Weronica E ^a,b   Levine, David M ^c   D'Amato, Mauro ^c   Pedersen, Nancy L ^c   Magnusson, Patrik K E ^c   Bresso, Francesca ^c,e   Onstad, Lynn E ^g   Schmidt, Peter T ^e   Törnblom, Hans ^h   Nordenstedt, Helena ^c   Romero, Yvonne ⁱ   Chow, Wong Ho ^j   Murray, Liam J ^k   Gammon, Marilie D ^l,n   Liu, Geoffrey ^o   Bernstein, Leslie ^p   Casson, Alan G ^q   Risch, Harvey A ^r   Shaheen, Nicholas J ^m   Bird, Nigel C ^s   Reid, Brian J ^g   Corley, Douglas A ^t   Hardie, Laura J ^u   Ye, Weimin ^d   Wu, Anna H ^v   Zucchelli, Marco ^c   Spector, Tim D ^w   Hysi, Pirro ^w   Vaughan, Thomas L ^f   Whiteman, David C ^a   MacGregor, Stuart ^a,b   more..

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF WASHINGTON   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e Division of Public Health Sciences   (United States)

^f Division of Human Biology   (United States)

^g Fred Hutchinson Cancer Research Center   (United States)

^h UNIVERSITY OF GOTHENBURG   (Sweden)

ⁱ MAYO CLINIC   (United States)

^j UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^k QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^l IL   (United States)

^m UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

ⁿ UNIVERSITY OF NORTH CAROLINA   (United States)

^o PRINCESS MARGARET HOSPITAL   (Canada)

^p CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^q UNIVERSITY OF SASKATCHEWAN   (Canada)

^r YALE UNIVERSITY   (United States)

^s UNIVERSITY OF SHEFFIELD   (United Kingdom)

^t DIVISION OF RESEARCH   (United States)

^u UNIVERSITY OF LEEDS   (United Kingdom)

^v UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^w ST THOMAS HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BARRETT ESOPHAGUS; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; FEMALE; GASTROESOPHAGEAL REFLUX; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC RISK; GENETIC TRAIT; GENETIC VARIABILITY; HERITABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR PHYLOGENY; PREDICTION; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SWEDEN; UNITED KINGDOM; X CHROMOSOME;

EID: 84890476691     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djt303     Document Type: Article

References (52)

1. Howlader N, Noone A, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). http://seer.cancer.gov/csr/1975-2009- pops09/. Accessed September 27, 2013.
2. Powell J, McConkey CC, Gillison EW, Spychal RT. Continuing rising trend in oesophageal adenocarcinoma. Int J Cancer. 2002;102(4):422-427.
3. Holmes RJ, Vaughan TL. Epidemiology and pathogenesis of esophageal cancer. Semin Rad Oncol. 2007;17(1):2-9.
4. Wong D, Paulson T, Prevo L, et al. p16INK4a Lesions are common, early abnormalities that undergo clonal expansion in barrett's metaplastic epithelium. Cancer Res. 2001;61(22):8284-8289.
5. Maley C, Rustgi A. Barrett's esophagus and its progression to adenocarcinoma. J Natl Compr Canc Netw. 2006;4(4):367-374.
6. Hvid-Jensen F, Pedersen L, Drewes A, Sørensen H, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med. 2011(365):1375-1383.
7. American Gastroenterological Association, Spechler S, Sharma P, Souza R, Inadomi J, Shaheen N. American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology. 2011;140(3):1084-1091.
8. Reid B, Li X, Galipeau P, Vaughan T. Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat Rev Cancer. 2010;10(2):87-101.
9. Olsen C, Pandeya N, Green A, Webb P, Whiteman D, Australian Cancer Study. Population attributable fractions of adenocarcinoma of the esophagus and gastroesophageal junction. Am J Epidemiol. 2011;1(174):582-590.
10. Engel L, Chow W, Vaughan T, et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst. 2003;95(18):1404-1413.
11. Poynton A, Walsh T, O'Sullivan G, Hennessy T. Carcinoma arising in familial Barrett's esophagus. Am J Gastroenterol. 1996;91(9):1855-1856.
12. Romero Y, Cameron A, Locke G, et al. Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma. Gastroenterol. 1997;113(5):1449-1456.
13. Chak A, Lee T, Kinnard M, et al. Familial aggregation of Barrett's oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults. Gut. 2002;51(3):323-328.
14. Munitiz V, Parrilla P, Ortiz A, Martinez-de-Haro L, Yelamos J, Molina J. High risk of malignancy in familial Barrett's esophagus: presentation of one family. J Clin Gastroenterol. 2008;42(7):806-809.
15. Groves C, Jankowski J, Barker F, Holdstock G. A family history of Barrett's oesophagus: Another risk factor? Scand J Gastroenterol. 2005;40(9):1127-1128.
16. Chak A, Faulx A, Kinnard M, et al. Identification of Barrett's esophagus in relatives by endoscopic screening. Am J Gastroenterol. 2004;99(11):2107-2114.
17. Fitzgerald R. Complex diseases in gastroenterology and hepatology: GERD, Barrett's, and esophageal adenocarcinoma. Clin Gastroenterol Hepatol. 2005;3(6):529-537.
18. Mohammed I, Cherkas L, Riley S, Spector T, Trudgill N. Genetic influences in gastro-oesophageal reflux disease: A twin study. Gut. 2003;52(8):1085-1089.
19. Cameron A, Lagergren J, Henriksson C, Nyren O, Locke GR 3rd, Pedersen NL. Gastroesophageal reflux disease in monozygotic and dizygotic twins. Gastroenterology. 2002;122(1):55-59.
20. The Esophageal Adenocarcinoma Genetics Consortium, The Wellcome Trust Case Control Consortium, Su Z, et al. Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus. Nat Genet. 2012;44(10):1131-1136.
21. Stranger B, Stahl E, Raj T. Progress and promise of genome-wide association studies for human complex trait genetics. Genetics 2011;187(2):367-383.
22. International Schizophrenia Consortium, Purcell S, Wray N, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009;460(7256):748-752.
23. Gibson G. Rare and common variants: twenty arguments. Nat Rev Genet. 2012;13(2):135-145.
24. Wray N, Goddard M, Visscher P. Prediction of individual genetic risk to disease from genome-wide association studies. Genome Res. 2007;17(10):1520-1528.
25. Yang J, Lee S, Goddard M, Visscher P. GCTA: A tool for genome-wide complex trait analysis. Am J Hum Genet. 2011;88(1):76-82.
26. Lee S, Wray N, Goddard M, Visscher P. Estimating missing heritability for disease from genome-wide association studies. Am J Hum Genet. 2011;88(3):294-305.
27. Lichtenstein P, Holm N, Verkasalo P, et al. Environmental and heritable factors in the causation of cancer -Analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343(2):78-85.
28. Spector TD, Williams FMK. The UK Adult Twin Registry (TwinUK) Twin Res Hum Genet. 2006;9(6):899-906.
29. Self GS, Liang K-Y. Asymptotic properties of maximum likelihood estimators and likelihood ratio tests under nonstandard conditions. J Am stat Assoc. 1987;82(398):605-610.
30. Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett's esophagus in the general population: An endoscopic study. Gastroenterology. 2005;129(6):1825-1831.
31. Dent J, El-Serag H, Wallander M, Johansson S. Epidemiology of gastrooesophageal reflux disease: A systematic review. Gut. 2005;54(5):710-717.
32. Lee S, Yang J, Goddard M, Visscher P, Wray N. Estimation of pleiotropy between complex diseases using single-nucleotide polymorphism-derived genomic relationships and restricted maximum likelihood. Bioinformatics. 2012;28(19):2540-2542.
33. Vattikuti S, Guo J, Chow C. Heritability and genetic correlations explained by common SNPs for metabolic syndrome traits. PLoS Genet. 2012;8(6)e1002637.
34. Blankenstein MV, Looman C, Johnston B, Caygill C. Age and sex distribution of the prevalence of Barrett's esophagus found in a primary referral endoscopy center. Am J Gastroenterol. 2005;100(3):568-576.
35. Derakhshan M, Liptrot S, Paul J, Brown I, Morrison D, McColl K. Oesophageal and gastric intestinal-Type adenocarcinomas show the same male predominance due to a 17 year delayed development in females. Gut. 2009;58(1):16-23.
36. Painter J, Anderson C, Nyholt D, et al. Genome-wide association study identifies a locus at 7p15.2 associated with endometriosis. Nat Genet. 2011;43(1):51-54.
37. Nagelkerke NJD. A note on a general definition of the coefficient of determination. Biometrika. 1991;78(3):691-692.
38. Corley D, Kubo A, Levin T, et al. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology. 2007;133(1):34-41.
39. Corley D, Kubo A, Zhao W. Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol Biomarkers Prev. 2008;17(2):352-358.
40. Cook M, Shaheen N, Anderson L, et al. Cigarette smoking increases risk of Barrett's esophagus: An analysis of the Barrett's and Esophageal Adenocarcinoma Consortium. Gastroenterology. 2012;142(4):744-753.
41. Edelstein Z, Farrow D, Bronner M, Rosen S, Vaughan T. Central adiposity and risk of Barrett's esophagus. Gastroenterology. 2007;133(2):403-411.
42. El-Serag H, Graham D, Satia J, Rabeneck L. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol. 2005;100(6):1243-1250.
43. Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux. Gut. 2004;53(12):1730- 1735.
44. Wu P, Ma L, Dai G, et al. The association of metabolic syndrome with reflux esophagitis: A case-control study. Neurogastroenterol Motil. 2011;23(11):989-994.
45. Kulig M, Nocon M, Vieth M, et al. Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study. J Clin Epidemiol. 2004;57(6):580-589.
46. Silventoinen K, Sammalisto S, Perols M, et al. Heritability of adult body height: A comparative study of twin cohorts in eight countries. Twin Res. 2003;6(5):399-408.
47. So HC, Gui AH, Cherny SS, Sham PC. Evaluating the heritability explained by known susceptibility variants: A survey of ten complex diseases. Genet Epidemiol. 2011;35(5):310-317.
48. Freedman ND, Abnet CC, Leitzmann MF, et al. A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol. 2007;165(12):1424-1433.
49. Brown LM, Devesa SS. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am. Apr 2002;11(2):235-256.
50. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24(14):2137-2150.
51. Corley D, Buffler P. Oesophageal and gastric cardia adenocarcinomas: Analysis of regional variation using the Cancer Incidence in Five Continents database. Int J Epidemiol. 2001;30(6):1415-1425.
52. Zhou X, Carbonetto P, Stephens M. Polygenic modeling with Bayesian sparse linear mixed models. PLos Gen. 2013;9(2):e1003264.